For citations:
Salnikova M.M. Course of malignant pheochromocytoma. Clinical case. Clinical Case in Oncology. 2024;2(3):53-61. (In Russ.) https://doi.org/10.62546/3034-1477-2024-2-3-53-61
Views PDF (Rus): 105
Fullscreen
Popular articles
Vol 1, No 1 (2023)
Vol 1, No 1 (2023)
Vol 1, No 1 (2023)
Vol 1, No 1 (2023)
Vol 1, No 1 (2023)
Article Tools
Email this article (Login required)
Email the author (Login required)
Email this article (Login required)
Email the author (Login required)
About the Author
Keywords
HER2
adrenal gland
brain metastases
breast cancer
carcinoid syndrome
checkpoint inhibitors
diagnostics
gastric cancer
immune checkpoint inhibitors
immune-mediated adverse events
immunohistochemistry
immunotherapy
neuroendocrine tumor
oncology
pembrolizumab
pheochromocytoma
quality of life
rare immune-mediated adverse events
surgical treatment
trastuzumab deruxtecan
unclassifiable tumors
198255, Veteranov Ave., 56, sq. 200, St. Petersburg, Russia
tel.: +7 (921) 741-45-54
e-mail: clinicaloncologycase@mail.ru
